BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,757 | -$28,435 | -$487 | $1,953 |
| Dep. & Amort. | $416 | $181 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $875 | $58 | $77 |
| Change in WC | $10,415 | $4,475 | $20 | $127 |
| Other Non-Cash | -$36,701 | -$389 | -$325 | -$2,246 |
| Operating Cash Flow | -$70,626 | -$23,293 | -$735 | -$88 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$533 | -$231 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$62,881 | -$33,985 | $0 | $0 |
| Inv. Sales/Matur. | $128,976 | $43,855 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $65,562 | $9,639 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $373,457 | $0 | $0 | $210 |
| Stock Issued | $22,222 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$11,691 | -$3,266 | $0 | $187,040 |
| Financing Cash Flow | $383,988 | $18,956 | $0 | $0 |
| Forex Effect | $29,153 | $0 | $0 | $0 |
| Net Chg. in Cash | $408,077 | $5,302 | -$735 | -$88 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $664 | $26,348 | $1,698 | $1,786 |
| End Cash | $408,741 | $31,650 | $963 | $1,698 |
| Free Cash Flow | -$71,159 | -$23,524 | -$735 | -$88 |